Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Glucose Monitoring Jan 23 | 2019Libre Reaches 1.3M Users; Abbott Q4 ’18 Earnings UpdatePurchase Blast
$599
Posted in: GLP-1RA, Other Jan 23 | 2019Oramed Initiates Ph1 Oral GLP-1RA; Zafgen and vTv Ph2 dataPurchase Blast
$599
Posted in: Bolus Insulin Jan 18 | 2019Thoughts on Afrezza Direct Purchase ProgramPurchase Blast$599
Posted in: SGLT2i Jan 18 | 2019Lexicon down ~24%; Post-adcom Call Summary and ThoughtsPurchase Blast$599
Posted in: SGLT2i Jan 17 | 2019Sota adcom vote split 8-8; on-time approval now in questionPurchase Blast$599
Posted in: GLP-1RA, SGLT2i Jan 17 | 2019New Trulicity Label Update: lower hypo cutoff, AWARD-10, and pre-filled syringe discontinuationPurchase Blast$599
Posted in: SGLT2i Jan 17 | 2019$LXRX Trading Halted Ahead of Sotagliflozin FDA AdcomPurchase Blast$599
Posted in: SGLT2i Jan 15 | 2019FENIX Analysis: Sotagliflozin FDA Adcom Briefing DocumentsPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, Insulin Delivery, SGLT2i Jan 08 | 2019JPM 2019 Day 2: LLY, SNY, LXRX, ABT, PODD, MYLPurchase Blast$599
Posted in: DPP-IVi, Glucose Monitoring, Insulin Delivery, SGLT2i Jan 07 | 2019JPM 2019 Day 1: DXCM, MDT, JNJ, MRK; New Bigfoot Deal with LillyPurchase Blast$599
Posted in: Glucose Monitoring Jan 05 | 2019SENS: Eversense XL US Pivotal Trial and Insulin Dosing Claim sPMAPurchase Blast$599
Posted in: Bolus Insulin, Other Jan 04 | 2019New Afrezza TV DTC campaign on Jan 14, 2019Purchase Blast$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery Jan 04 | 2019New Medtronic IQcast Feature And Adocia RAI iLet TrialPurchase Blast$599
Posted in: GLP-1RA + Basal Jan 03 | 2019New Novo Ph1 Combo Study of QW Insulin 287 + OzempicPurchase Blast$599
Posted in: Other Dec 21 | 2018LX2761 positive Ph1 topline results and JDRF’s 2018 T1D research developmentsPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other Dec 21 | 2018Thoughts on 2019 ADA Standards of CarePurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
